← Back
$KURA All transactions

Kura Oncology, Inc.

▼ SELL

$ Value

$51K

Shares

4,539

Price

$11

Filed

Nov 14

Insider

Name

DOYLE THOMAS JAMES

Title

SVP, Finance & Accounting

CIK

0001910331

Roles

Officer

Transaction Details

Transaction Date

2025-11-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

130,257

Footnotes

Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.

Filing Info

Accession No.

0001193125-25-283562

Form Type

4

Issuer CIK

0001422143

DOYLE THOMAS JAMES's History

Date Ticker Type Value
2026-01-27 KURA $19K
2026-01-27 KURA $9K
2026-01-27 KURA $6K
2026-01-27 KURA $19K
2026-01-27 KURA $7K
2026-01-02 KURA A $0
2026-01-02 KURA A $0
2025-11-14 KURA $51K
2025-11-13 KURA A $0
2025-09-29 KURA $41K

Other Insiders at KURA (90d)

Insider Bought Sold Last
WILSON TROY EDWARD
President and CEO
2026-03-23
FORD KATHLEEN
Chief Operating Officer
$15K 2026-01-27
Bair Teresa Brophy
Chief Legal Officer
$95K 2026-01-27
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$60K 2026-01-27
Powl Brian T.
Chief Commercial Officer
$54K 2026-01-27
Leoni Mollie
Chief Medical Officer
$69K 2026-01-27
Burrows Francis
Chief Scientific Officer
$11K 2026-01-27